TrialPloS one2014

A combined analysis of 48 type 2 diabetes genetic risk variants shows no discriminative value to predict time to first prescription of a glucose lowering drug in Danish patients with screen detected type 2 diabetes.

Malene Hornbak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.